Generated by AI
SOPHiA GENETICS SA Ordinary Shares is the equity of SOPHiA GENETICS, a healthcare technology company focused on data-driven medicine and life sciences research. The company develops cloud-native software that analyzes complex genomic and multimodal healthcare data, helping hospitals, laboratories, and biopharmaceutical organizations generate actionable insights across cancer, rare disorders, and other diagnostic areas. Its core platform, SOPHiA DDM, supports the interpretation of data from multiple testing modalities, including genomics, radiomics, clinical information, biological data, and digital pathology. SOPHiA GENETICS serves a global network of healthcare and research institutions that use its software to streamline analysis and support more coordinated diagnostic workflows. Headquartered in Rolle, Switzerland, SOPHiA GENETICS operates at the intersection of healthcare, artificial intelligence, and precision medicine, making it an important provider of digital tools for modern clinical and research environments.
WebsiteLa PiEce 12
Rolle, 1180
Switzerland
The latest articles about SOPH.
Summary of Nov 16's posts. Generated by AI.
Summary of Oct 23's posts. Generated by AI.
Summary of Jul 22's posts. Generated by AI.
No summary yet.
Summary of Nov 15's posts. Generated by AI.
Investors talking about SOPH also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.